Enhanced production of nukacin D13E in Lactococcus lactis NZ9000 by the additional expression of immunity genes

Tijo Varghese Puramattathu, Mohammad R. Islam, Mami Nishie, Sae Yanagihara, Jun Ichi Nagao, Ken Ichi Okuda, Takeshi Zendo, Jiro Nakayama, Kenji Sonomoto

研究成果: ジャーナルへの寄稿学術誌査読

3 被引用数 (Scopus)

抄録

Nukacin D13E (D13E) is a variant of type-A(II) lantibiotic nukacin ISK-1 produced by Staphylococcus warneri ISK-1. D13E exhibited a twofold higher specific antimicrobial activity than nukacin ISK-1 against a number of Gram-positive bacteria. We previously reported the heterologous production of D13E in Lactococcus lactis NZ9000 under the control of nisin-controlled gene expression system. In this study, we demonstrated enhanced production of D13E by the additional expression of immunity genes, nukFEG. The nukacin ISK-1 immunity, conferred by the ABC transporter complex, NukFEG, and the lantibiotic-binding protein, NukH, was not overwhelmed by D13E. The additional NukFEG resulted in a fourfold increase in the immunity level of the strain and a 5.2-fold increase in D13E production. The additional NukFEGH-expressing strain with the highest D13E immunity showed reduced level of production. Further improvement in D13E production was achieved by using pH-controlled batch fermentation.

本文言語英語
ページ(範囲)671-678
ページ数8
ジャーナルApplied Microbiology and Biotechnology
93
2
DOI
出版ステータス出版済み - 1月 2012

!!!All Science Journal Classification (ASJC) codes

  • バイオテクノロジー
  • 応用微生物学とバイオテクノロジー

フィンガープリント

「Enhanced production of nukacin D13E in Lactococcus lactis NZ9000 by the additional expression of immunity genes」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル